A phase II, randomized, non-comparative clinical trial of the effect of bevacizumab (BV) alone or in combination with irinotecan (CPT) on 6-month progression free survival (PFS6) in recurrent, treatment-refractory glioblastoma (GBM) Meeting Abstract
| Authors: | Cloughesy, T. F.; Prados, M. D.; Wen, P. Y.; Mikkelsen, T.; Abrey, L. E.; Schiff, D.; Yung, W. K.; Maoxia, Z.; Dimery, I.; Friedman, H. S. |
| Abstract Title: | A phase II, randomized, non-comparative clinical trial of the effect of bevacizumab (BV) alone or in combination with irinotecan (CPT) on 6-month progression free survival (PFS6) in recurrent, treatment-refractory glioblastoma (GBM) |
| Meeting Title: | 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 26 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2008 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2008-05-20 |
| Start Page: | 91s |
| Language: | English |
| ACCESSION: | WOS:000208457400472 |
| DOI: | 10.1200/jco.2008.26.15_suppl.2010b |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2010b -- Source: Wos |
